Post-Earnings Volatility: Social media chatter focused on Rocket Lab shares experiencing a notable 25% pullback in just four days. Observers highlighted how the move erased much of the post-May earnings gains despite the company's underlying business momentum remaining intact. Discussions emphasized that price action alone does not alter the core investment thesis.
Technical Resilience: Market participants described the chart as exhibiting one of the cleanest uptrends in the sector, complete with a series of higher highs and lows. Attention centered on the stock's consolidation near the psychologically important $100 level amid signs of bullish divergence in momentum indicators. Some noted this setup could support a resumption of the prior advance if support holds.
Long-Term Conviction: Investors voiced continued commitment to the name for the multi-year horizon, pointing to Rocket Lab's position in the expanding space economy. Commentary stressed that short-term liquidity events have not diminished enthusiasm for the company's growth trajectory. Overall views reflected patience through near-term fluctuations.
Note: This discussion summary was generated from an AI condensation of post data.
Rocket Lab Insider Trading Activity
Rocket Lab insiders have traded $RKLB stock on the open market 110 times in the past 6 months. Of those trades, 0 have been purchases and 110 have been sales.
Here’s a breakdown of recent trading of $RKLB stock by insiders over the last 6 months:
- ADAM C. SPICE (Chief Financial Officer) has made 0 purchases and 18 sales selling 1,491,153 shares for an estimated $116,424,260.
- ARJUN KAMPANI (SVP & General Counsel) has made 0 purchases and 27 sales selling 262,944 shares for an estimated $30,965,212.
- ALEXANDER R SLUSKY has made 0 purchases and 7 sales selling 200,000 shares for an estimated $25,715,726.
- FRANK KLEIN (Chief Operations Officer) has made 0 purchases and 33 sales selling 262,500 shares for an estimated $24,798,755.
- MERLINE SAINTIL has made 0 purchases and 3 sales selling 126,626 shares for an estimated $10,796,851.
- MARVIN BRADFORD CLEVENGER (President, Rocket Lab USA, Inc) has made 0 purchases and 7 sales selling 19,049 shares for an estimated $2,730,231.
- JON A OLSON has made 0 purchases and 10 sales selling 15,205 shares for an estimated $1,388,221.
- PETER BECK (CEO) has made 0 purchases and 5 sales selling 18,857 shares for an estimated $1,312,257.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Rocket Lab Revenue
Rocket Lab had revenues of $200.3M in Q1 2026. This is an increase of 63.46% from the same period in the prior year.
You can track RKLB financials on Quiver Quantitative's RKLB stock page.
You can access data on RKLB stock through the Quiver Quantitative API.
Rocket Lab Hedge Fund Activity
We have seen 541 institutional investors add shares of Rocket Lab stock to their portfolio, and 364 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 8,958,642 shares (-55.3%) from their portfolio in Q1 2026, for an estimated $575,323,989
- VK SERVICES, LLC removed 8,323,617 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $580,655,521
- CAPITAL INTERNATIONAL INVESTORS added 6,701,140 shares (+inf%) to their portfolio in Q1 2026, for an estimated $430,347,210
- BAILLIE GIFFORD & CO added 5,725,536 shares (+47.2%) to their portfolio in Q4 2025, for an estimated $399,413,391
- VANGUARD GROUP INC added 5,610,469 shares (+13.4%) to their portfolio in Q4 2025, for an estimated $391,386,317
- DEFIANCE ETFS, LLC added 5,595,925 shares (+18556.6%) to their portfolio in Q1 2026, for an estimated $359,370,303
- BLACKROCK, INC. added 4,909,667 shares (+14.8%) to their portfolio in Q1 2026, for an estimated $315,298,814
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Rocket Lab Government Contracts
We have seen $21,359,603 of award payments to $RKLB over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- VENTURE-CLASS ACQUISITION OF DEDICATED AND RIDESHARE (VADR) UMBRELLA TASK ORDER: $19,989,522
- THE CONTRACTOR SHALL DEVELOP GEN 1 SOLAR SAIL MISSION CONCEPTS THAT WILL ADDRESS THE OBJECTIVES OF A FUTURE...: $546,480
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
Rocket Lab Analyst Ratings
Wall Street analysts have issued reports on $RKLB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 01/20/2026
- Morgan Stanley issued a "Overweight" rating on 01/16/2026
To track analyst ratings and price targets for Rocket Lab, check out Quiver Quantitative's $RKLB forecast page.
Rocket Lab Price Targets
Multiple analysts have issued price targets for $RKLB recently. We have seen 14 analysts offer price targets for $RKLB in the last 6 months, with a median target of $105.0.
Here are some recent targets:
- Michael Leshock from Keybanc set a target price of $135.0 on 06/15/2026
- An analyst from KGI Securities set a target price of $105.0 on 06/11/2026
- Edison Yu from Deutsche Bank set a target price of $120.0 on 05/12/2026
- Ryan Koontz from Needham set a target price of $120.0 on 05/11/2026
- Trevor Walsh from Citizens set a target price of $95.0 on 05/08/2026
- Gautam Khanna from TD Cowen set a target price of $120.0 on 05/08/2026
- Erik Rasmussen from Stifel set a target price of $105.0 on 04/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.